Literature DB >> 3924997

Two-color immunofluorescence and flow cytometry analysis of lymphocytes in long-term renal allotransplant recipients: identification of a major Leu-7+/Leu-3+ subpopulation.

C M Legendre, R D Guttmann, S K Hou, R Jean.   

Abstract

Using two-color immunofluorescence with fluorescein isothiocyanate (FITC)- and phycoerythrin (PE)-labeled monoclonal antibodies to human lymphocyte antigens and flow cytometry, we studied lymphocyte subsets in 16 long-term renal allotransplant recipients at risk for a mean of 78 +/- 15 mo. The absolute number of Leu-1+, Leu-2a+, and Leu-3a+ lymphocytes is significantly decreased compared with a control population, whereas Leu-7+ and Leu-15+ subsets remain unchanged despite standard chronic immunosuppression (azathioprine and prednisone). Within the Leu-7+ subset, we found various phenotypes. Doubly fluorescent lymphocytes Leu-7+/Leu-1+ and Leu-7+/Leu-2a+ are not significantly different in the transplant population compared with a normal control population. The Leu-7+/Leu-3a+ subpopulation is seen to be significantly elevated, and the Leu-7+/Leu-15+ subpopulation decreases significantly. The relationship between the modification of these two phenotypes within the Leu-7 subset may be an important correlate of decreased NK cell activity in long-term renal allotransplant recipients. These Leu-7+/Leu-3a+ cells, normally less than 1% of peripheral blood lymphocytes, have no known functional activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3924997

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  CD3+ CD57+ lymphocytes are not likely to be involved in antigen-specific rejection processes in long-term allograft recipients.

Authors:  B Reipert; C Scheuch; A Lukowsky; P Reinke; E Fietze; W D Döcke; G Staffa; S Czerlinksi; R Hetzer; H D Volk
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

2.  Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn's disease.

Authors:  M Senju; F Hulstaert; J Lowder; D P Jewell
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

3.  Increase in CD57 + CD16-lymphocytes in workers exposed to benzidine and beta-naphthylamine: assessment of natural killer cell subpopulations.

Authors:  T Tanigawa; S Araki; T Abo; S Sakurai
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

4.  The influence of cytomegalovirus carrier status on lymphocyte subsets and natural immunity.

Authors:  J W Gratama; M Kardol; A M Naipal; J Slats; A Den Ouden; T Stijnen; J D'Amaro; T H The; J W Bruning
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

5.  Immunophenotypical alterations in a subset of patients with common variable immunodeficiency (CVID).

Authors:  E Baumert; G Wolff-Vorbeck; M Schlesier; H H Peter
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

6.  CD57(+) CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection.

Authors:  J Espinosa; F Herr; G Tharp; S Bosinger; M Song; A B Farris; R George; J Cheeseman; L Stempora; R Townsend; A Durrbach; A D Kirk
Journal:  Am J Transplant       Date:  2016-01-14       Impact factor: 8.086

7.  T cells expressing high levels of non-major histocompatibility complex (MHC)-restricted cytotoxicity are present in early and late clinical phases of human immunodeficiency virus 1 (HIV-1) infection.

Authors:  J E Morgan; C B Daul; R D de Shazo; W A Andes; N H Hyslop
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

8.  Impact of cytomegalovirus and grafts versus host disease on the dynamics of CD57+CD28-CD8+ T cells after bone marrow transplant.

Authors:  Ana Verena Almeida Mendes; Esper Georges Kallas; Gil Benard; Cláudio Sérgio Pannuti; Reneé Menezes; Frederico Luiz Dulley; Thomas George Evans; Reinaldo Salomão; Clarisse Martins Machado
Journal:  Clinics (Sao Paulo)       Date:  2008-10       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.